dRx Capital
Overview
"dRx Capital is a joint investment company created by Novartis and Qualcomm, leading innovation in digital medicines. The company will invest up to USD 100 million in early stage companies with ""beyond the pill"" products or services."
Investment Focus
- Innovative digital health solutions
- Strong management teams
- Scalable business models
- Potential for significant impact on patient care and outcomes
Portfolio Companies
Reach dRx Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about dRx Capital
What sectors does dRx Capital invest in?
dRx Capital invests in Technology, Healthcare, Artificial Intelligence, Life Sciences, Digital Health and Pharmaceuticals, and is based in San Diego, California, United States. dRx Capital is listed as a vc in the ConnectSafely investor database.
What stage does dRx Capital invest at?
dRx Capital backs companies at Seed, Early Stage, Series A, Series B and Growth, writing cheques of $3M - $10M.
Which regions does dRx Capital invest in?
dRx Capital invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has dRx Capital invested in?
dRx Capital's portfolio includes Omada Health, Freenome, Cala Health, Aspen RxHealth, Pear Therapeutics, Flywheel, Somalogic and Xealth.
How do I contact dRx Capital?
dRx Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
